B7.1/B7.2 and CTLA4 expression on feline T cells in vitro correlates with apoptosis

被引：0
|
作者：
Vahlenkamp, TW
Bull, ME
Dow, J
Anderson, J
Tompkins, MB
Tompkins, WAF
机构：
[1] N Carolina State Univ, Coll Vet Med, Dept Microbiol Pathol & Parasitol, Raleigh, NC 27606 USA
[2] N Carolina State Univ, Coll Vet Med, Dept Farm Anim Hlth & Resource Management, Raleigh, NC 27606 USA
来源：
JOURNAL OF LEUKOCYTE BIOLOGY | 2001年
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
255
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [41] Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses
    Ahmad, Sheikh Fayaz
    Zoheir, Khairy M. A.
    Ansari, Mushtaq Ahmad
    Nadeem, Ahmed
    Bakheet, Saleh A.
    Al-Hoshani, Ali R.
    Al-Shabanah, Othman A.
    Al-Harbi, Mohammed M.
    Attia, Sabry M.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 : 30 - 42
  • [42] Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
    Short, JJ
    Pereboev, AV
    Kawakami, Y
    Vasu, C
    Holterman, MJ
    Curiel, DT
    VIROLOGY, 2004, 322 (02) : 349 - 359
  • [43] CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma
    Serebrisky, D
    Teper, AA
    Huang, CK
    Lee, SY
    Zhang, TF
    Schofield, BH
    Kattan, M
    Sampson, HA
    Li, XM
    JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5906 - 5912
  • [44] B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance
    Liu, LM
    Kuchroo, VK
    Weiner, HL
    JOURNAL OF IMMUNOLOGY, 1999, 163 (04): : 2284 - 2290
  • [45] Costimulation by CD80 (B7.1) and CD86 (B7.2) induce comparable Jun kinase expression and T cell activation but show differential susceptibility to antibody treatment in allergic responses in vitro
    Haczku, A
    Nagasawa, M
    Gelfand, E
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S107 - S107
  • [46] T cell-mediated elimination of B7.2 transgenic B cells
    Fournier, S
    Rathmell, JC
    Goodnow, CC
    Allison, JP
    IMMUNITY, 1997, 6 (03) : 327 - 339
  • [47] Treatment with antibodies to B7.1, B7.2 or CD40L prevents IDDM in a transgenic model of virus-induced diabetes
    Von Herrath, M
    DIABETES, 1998, 47 : A210 - A210
  • [48] B7.1 immunogene therapy effectively activates CD4+ tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy
    Ando, H
    Saio, M
    Ohe, N
    Tamakawa, N
    Yu, H
    Nakayama, T
    Yoshimura, S
    Kaku, Y
    Iwama, T
    Shinoda, J
    Sakai, N
    Takami, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (04) : 807 - 812
  • [49] LOCALIZATION IN-SITU OF THE COSTIMULATORY MOLECULES B7.1, B7.2, CD40 AND THEIR LIGANDS IN NORMAL HUMAN LYMPHOID-TISSUE
    VYTHDREESE, FA
    DELLEMIJN, TAM
    MAJOOR, D
    DEJONG, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3023 - 3029
  • [50] CTLA-4+ CD8+ T cells that encounter B7.2+ iris pigment epithelial cells express their own B7.2 to achieve global suppression of T cell activation
    Schwartzkopff, J
    Sugita, S
    Ng, TF
    Streilein, JW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U214 - U214
12345